文献速递分子诊断质量管理与危急值

利用Unity Real Time管理巨细胞病毒、EB病毒和HIV病毒载量质控数据

Management of Cytomegalovirus, Epstein-Barr Virus, and HIV Viral Load Quality Control Data Using Unity Real Time.
PubMed 文献 · J Clin Microbiol · 2021-10-20

本研究从文献确定总允许误差(TEa),使用Unity Real Time软件管理FDA批准/清除的Abbott巨细胞病毒(CMV)和HIV病毒载量检测及实验室自建的EB病毒(EBV)病毒载量检测的质控数据并评估检测性能。基于73至83天检测的阴性、低阳性和高阳性对照数据计算均值、标准差和变异系数,以TEa为0.5 log10计算Sigma值:EBV为5.06,预测每百万患者检测约230个错误结果(0.02%频率);CMV为11.32、HIV为7.66,均>6,表明每百万患者检测<4个错误结果。Unity Real Time质控设计模块利用这些Sigma值推荐质控规则,为放宽实验室现有质控规则提供客观证据,对变异最大的EBV病毒载量检测可将假拒绝率降低10倍。

要点

  • EBV病毒载量检测Sigma值为5.06,预测每百万患者检测约230个错误结果(0.02%频率)。
  • CMV(11.32)和HIV(7.66)的Sigma值均>6,表明每百万患者检测<4个错误结果。
  • Unity Real Time质控设计模块基于Sigma值推荐质控规则,可将EBV病毒载量检测的假拒绝率降低10倍。

核心结论

  • Unity Real Time软件可基于Sigma值评估分子病毒载量检测性能并优化质控规则,在保证患者安全的同时降低假拒绝率。

研究设计与样本

  • 本研究从文献确定总允许误差(TEa),使用Unity Real Time软件管理FDA批准/清除的Abbott CMV和HIV病毒载量检测及实验室自建EBV病毒载量检测的质控数据。
  • 基于73至83天检测的阴性、低阳性和高阳性对照数据计算均值、标准差和变异系数,并以TEa为0.5 log10计算Sigma值。

主要发现

  • EBV病毒载量检测Sigma值为5.06,预测每百万患者检测约230个错误结果(0.02%频率)。
  • CMV病毒载量检测Sigma值为11.32,HIV病毒载量检测Sigma值为7.66,均>6,表明每百万患者检测<4个错误结果。
  • Unity Real Time质控设计模块利用Sigma值推荐质控规则,为放宽实验室现有质控规则提供客观证据。
  • 对变异最大的EBV病毒载量检测,放宽质控规则可将假拒绝率降低10倍。

关键数值与推荐

  • 总允许误差(TEa)设定为0.5 log10。
  • EBV病毒载量检测Sigma值为5.06,预测每百万患者检测约230个错误结果(0.02%频率)。
  • CMV病毒载量检测Sigma值为11.32,HIV病毒载量检测Sigma值为7.66,均>6,表明每百万患者检测<4个错误结果。

临床怎么用

  • 实验室可使用Unity Real Time软件基于Sigma值评估分子病毒载量检测性能,并制定常规监测的最优质控规则。
  • 基于Sigma值推荐的质控规则可为放宽现有质控规则提供客观证据,从而降低假拒绝率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Quality control (QC) rules (Westgard rules) are applied to viral load testing to identify runs that should be reviewed or repeated, but this requires balancing the patient safety benefits of error detection with the cost and inefficiency of false rejection. In this study, we identified the total allowable errors (TEa) from the literature and utilized a commercially available software program (Unity Real Time; Bio-Rad Laboratories) to manage QC data, assess assay performance, and provide QC decision support for both FDA-approved/cleared (Abbott cytomegalovirus [CMV] and HIV viral load) as well as laboratory-developed (Epstein-Barr virus [EBV] viral load) assays. Unity Real Time was used to calculate means, standard deviations (SDs), and coefficient of variation (CV; in percent) of negative, low-positive, and high-positive control data from 73 to 83 days of testing. Sigma values were calculated to measure the test performance relative to a TEa of 0.5 log10. The sigma value of 5.06 for EBV predicts ∼230 erroneous results per million individual patient tests (0.02% frequency), whereas sigma values of >6 for CMV (11.32) and HIV (7.66) indicate <4 erroneous results per million individual patient tests. The Unity Real Time QC Design module utilized these sigma values to recommend QC rules and provided objective evidence for loosening the laboratory's existing QC rules for run acceptability, potentially reducing false rejection rates by 10-fold for the assay with the most variation (EBV viral load). This study provides a framework for laboratories, with Unity Real Time as a tool, to evaluate assay performance relative to clinical decision points and establish optimal rules for routine monitoring of molecular viral load assay performance.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Newton DW, Vandepoele N, Yundt-Pacheco JC, et al. Management of Cytomegalovirus, Epstein-Barr Virus, and HIV Viral Load Quality Control Data Using Unity Real Time. J Clin Microbiol. 2021. PMID: 34669458. doi:10.1128/JCM.01675-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。